Cardlytics (CDLX) Tops Q4 EPS by 37c
Cardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.05), $0.37 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $90 million versus the consensus estimate of $76.58 million.
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
